PACLITAXEL ALBUMIN-BOUND, NIVOLUMAB, CISPLATIN
CA209-6E8, CNN-BC
Phase 2 small_molecule active
Quick answer
PACLITAXEL ALBUMIN-BOUND, NIVOLUMAB, CISPLATIN for Patients with non-metastatic muscle invasive bladder cancer is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Patients with non-metastatic muscle invasive bladder cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active